Publication | Closed Access

Tissue-type plasminogen activator and Type-1 plasminogen activator inhibitor in patients with coronary artery disease — Relations to clinical variables and cardiovascular risk factors

ThrombosisCardiovascular EpidemiologyCardiovascular DiseasePharmacologyCardiovascular PharmacologyClinical VariablesVascular BiologyCardiovascular Risk FactorsTissue-type Plasminogen ActivatorPublic HealthMedicineCardiovascular Disease PathogenesisCardiologyEpidemiologyCoronary Artery DiseaseCoronary Heart DiseaseMyocardial Infarction